Trending Topics

7 hours ago

7 Challenges in scaling RNA Therapeutics Manufacturing

Breaking News

  • 22 hours ago

  • Simantini Singh Deo

Boehringer Ingelheim Achieves Phase III Survival Signal with Nerandomilast in IPF and PPF
Breaking News

More News

Roche Gains FDA sBLA Acceptance for Lunsumio VELO Plus Polivy in Relapsed or Refractory LBCL

Roche Gains FDA sBLA Acceptance for Lunsumio VELO Plus Polivy in Relap...

Simantini Singh Deo

Ad
Advertisement

Interviews & Opinions

Article

Mehul Shah took 11 years to hit Rs 25 crore in turnover, then waited again before owning his own R&D. On the ₹250 stipend, building Volini, the PACO f...

FT - Mr. Mehul Shah

Read More

Article
From Microbiologist to Pharma Leader : Hemanth Panasa on FDA Audits, Contamination Control & Aseptic Failures

FT - Mr. Hemanth Panasa

Ad
Advertisement
Ad